Oncology medicine spending at list prices vs Oncology novel active substance (NAS) launches (cumulative)
Oncology medicine spending at list prices and Oncology novel active substance (NAS) launches (cumulative) worldwide, compared over time.
Change the pair
Compare different indicators
The series
Over time
Global, spaced by time . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.
Oncology medicine spending at list prices
Unit: billion USD · 2 observations
Forecast: dashed line, hollow markers, shaded band
Oncology novel active substance (NAS) launches (cumulative)
Unit: count · 3 observations
Provenance
Where these numbers come from
Oncology medicine spending at list prices
Total spending on cancer medicines valued at list prices.
2 observations in Global · source organisations: IQVIA
Oncology novel active substance (NAS) launches (cumulative)
Total number of oncology novel active substances launched over a stated multi-year period.
3 observations in Global · source organisations: IQVIA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring